HONG KONG (Reuters) - Baidu Inc (BIDU.O) and JD.com (JD.O) will join other big Chinese technology firms to jointly invest about $12 billion in the Shanghai-listed unit of China Unicom, the weakest of three big state-owned telecoms firms, two people with ... ( read original story ...)
China stocks end week higher as investors plough into blue chips
China's opening up its stock market to foreign investors by the Shanghai, Shenzhen and Hong Kong connect programmes, as well as by the MSCI's decision to include China stocks, also helped prompt a rotation into blue chips, Xu added. US index provider MSCI ... ( read original story ...)
Chinese courier ZTO sued for “untrue statements” in $1.4 billion U.S. IPO
ZTO's listing was the largest U.S. listing in 2016 and was the biggest by a Chinese company since the $25 billion IPO of e-commerce giant Alibaba Group Holding Ltd in 2014. Shares in Shanghai-based ZTO closed on Thursday at $15.68, about 20 percent below ... ( read original story ...)
Investors are behaving less like casino punters in China’s stock markets
SHANGHAI/HONG KONG: Retired chauffeur Yao Huiliang used to ... Anthony Cragg, senior portfolio manager at Wells Fargo Asset Management, said the character of China's stock market was changing as domestic investors focused more on whether a company had ... ( read original story ...)
CIFF Shanghai announces themes
CIFF-Shanghai 2017 will also have a pavilion (North Hall) dedicated to intelligent customization (Intelligent Customization Home Furnishing Science and Technology Hall) in collaboration with the China Furniture and Decoration Chamber of Commerce. ( read original story ...)
Foreign funds stay away from Shanghai, in biggest slump since 2010
Shanghai, the megacity that’s been the epitome of mainland ... in a sign that growing protectionism, rising costs and a tougher business environment are pushing global companies to look elsewhere. Contracted foreign funds, an indicator of future ... ( read original story ...)
Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block – sources
U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said. Shanghai ... ( read original story ...)